EPS Bio TechnologyROCO:4183 63 Pretax Margin % is -1.17% as of Dec. 2025. GuruFocus rates ROCO:4183 with a GF Score™ of 63/100 and a GF Value™ of NT$22.94 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 818 Medical Devices & Instruments companies, EPS Bio Technology ranks worse than 55.62% on this metric.
The historical rank and industry rank for EPS Bio Technology's Pretax Margin % or its related term are showing as below:
ROCO:4183'
s Pretax Margin % Range Over the Past 10 Years
Min: -1.94 Med: 5.07 Max: 8.39
Current: -1.94
ROCO:4183's Pretax Margin % is ranked worse than 55.62% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs ROCO:4183: -1.94
EPS Bio Technology (ROCO:4183) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
EPS Bio Technology Pretax Margin % Related Terms
EPS Bio Technology Pretax Margin % Historical Data
* Premium members only.
The historical data trend for EPS Bio Technology's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4183 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, EPS Bio Technology's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EPS Bio Technology Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EPS Bio Technology's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where EPS Bio Technology's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS Bio Technology (ROCO:4183) has a Pretax Margin % of -1.17% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on EPS Bio Technology and its competitors. According to the industry distribution chart, EPS Bio Technology ranks #455 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 55.6%.
Is EPS Bio Technology's Pretax Margin % too high?
EPS Bio Technology's current Pretax Margin % is -1.17%. Based on the distribution chart, EPS Bio Technology ranks #455 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, EPS Bio Technology has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EPS Bio Technology's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EPS Bio Technology ranks #455 out of 818 companies for Pretax Margin %. This places EPS Bio Technology in the lower half of its industry. The industry median Pretax Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on EPS Bio Technology and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EPS Bio Technology's current Pretax Margin % is -1.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Bio Technology stock overvalued right now?
Based on GuruFocus' analysis, EPS Bio Technology (ROCO:4183) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$22.94, compared to a current price of NT$14.00 — trading 39% below its estimated fair value. The current Pretax Margin % is -1.17%. EPS Bio Technology's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For EPS Bio Technology (ROCO:4183), the current Pretax Margin % is -1.17% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EPS Bio Technology (ROCO:4183) Overvalued in 2026?
Based on GuruFocus' analysis, EPS Bio Technology stock appears to be undervalued.
The current stock price of NT$14.00 is trading 39% below its estimated GF Value™ of NT$22.94.
GuruFocus considers EPS Bio Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4183:
Pretax Margin %: -1.17%
GF Value™: NT$22.94 vs. price of NT$14.00 (39% below fair value)
No single metric tells the full story. See the ROCO:4183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
63GF Score
Get the complete analysis for ROCO:4183
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4183 has been successfully added to your 
